A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations.

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

A "living drug" Qartemi has been approved for blood cancer patients in India who suffer from an advanced or relapsed stage of ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

A team of researchers from the National University of Singapore (NUS) has developed a novel method to enhance the precision ...

Luke's cancer battle sparked his family to campaign in Washington, D.C., to help other families going through the same thing ...

Princess Kate recently shared the uplifting news of being in remission from cancer, bringing relief and joy to royal watchers ...

Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...